abm hsa mirna inhibitor

hsa miR miRNA Inhibitor ABM


Non-coding RNAs and significantly microRNAs have been discovered to behave as grasp regulators of most cancers initiation and improvement. The intention of our analysis was to seek out and characterize the carry out of however functionally uncharacterized microRNAs in human breast carcinogenesis.

miRNA inhibitors block miRNA regulation of purpose gene expression by safe suppression and may knock down native miRNA expression in cells. They are often utilized in miRNA loss-of-function analysis, miRNA purpose site identification and validation, and miRNA screening experiments. abm‘s Lentivirus miRNA Inhibitors allow for safe, long term expression of miRNA inhibitors out of your cell line.

Key Choices

  • We offer a gaggle of miRNA Inhibitors for knockdown of over 5000 miRNAs from human, mouse, and rat.
  • Lentiviral provide for integration of genetic supplies into host cells, inflicting safe, long term gene expression.
  • Lentivirus has a broad host differ and may infect every dividing and non-dividing cells, allowing gene provide to every kind of cell types.

For gene regulation and helpful analysis, abm presents a variety of expression strategies for:

  1. siRNA: successfully categorical any purpose siRNA to knockdown any gene with out the need to design hair-pin loop shRNA constructions, obtainable in lentivirus, AAV and Adenovirus.
  2. miRNA: inhibit or over-express any miRNA for analysis of post-transcriptional gene regulation in mammalian strategies using our ready-to-use viral vectors and packaged viruses, along with our detection and quantification devices.
  3. UTR Reporters: quantitatively analysis a specific miRNA’s regulation of its purpose gene using our 3’UTR or 5’UTR platform, all obtainable as a library of premade lentiviral vectors and lentiviruses for any human, mouse or rat gene.

abm hsa mirna inhibitor
abm hsa mirna inhibitor



In an unbiased technique, we utilized a longtime model system for breast most cancers (BC) stem cell formation (“mammosphere assay”) to determine full miRNome alterations in breast carcinogenesis. Medical samples of BC victims had been used to guage the human relevance of the newly acknowledged miRNA candidates. One promising candidate, miR-1287-5p, was further explored on its impression on quite a lot of hallmarks of most cancers. The molecular mode of movement was characterised by full transcriptome analysis, in silico prediction devices, miRNA-interaction assays, pheno-copy assays, and drug sensitivity assays.

hsa-let-7b miRNA Inhibitor
MIH01004 2 x 5.0 nmol
EUR 176
hsa-let-7c miRNA Inhibitor
MIH01007 2 x 5.0 nmol
EUR 176
hsa-let-7d miRNA Inhibitor
MIH01010 2 x 5.0 nmol
EUR 176
hsa-let-7e miRNA Inhibitor
MIH01013 2 x 5.0 nmol
EUR 176
hsa-let-7g miRNA Inhibitor
MIH01020 2 x 5.0 nmol
EUR 176
hsa-let-7i miRNA Inhibitor
MIH01023 2 x 5.0 nmol
EUR 176
hsa-miR-1 miRNA Inhibitor
MIH01026 2 x 5.0 nmol
EUR 176
hsa-miR-100 miRNA Inhibitor
MIH01027 2 x 5.0 nmol
EUR 176
hsa-miR-101 miRNA Inhibitor
MIH01030 2 x 5.0 nmol
EUR 176
hsa-miR-103 miRNA Inhibitor
MIH01033 2 x 5.0 nmol
EUR 176
hsa-miR-103b miRNA Inhibitor
MIH01037 2 x 5.0 nmol
EUR 176
hsa-miR-105 miRNA Inhibitor
MIH01038 2 x 5.0 nmol
EUR 176
hsa-miR-106a miRNA Inhibitor
MIH01041 2 x 5.0 nmol
EUR 176
hsa-miR-106b miRNA Inhibitor
MIH01044 2 x 5.0 nmol
EUR 176
hsa-miR-107 miRNA Inhibitor
MIH01047 2 x 5.0 nmol
EUR 176
hsa-miR-10a miRNA Inhibitor
MIH01048 2 x 5.0 nmol
EUR 176
hsa-miR-10b miRNA Inhibitor
MIH01051 2 x 5.0 nmol
EUR 176
hsa-miR-1178 miRNA Inhibitor
MIH01054 2 x 5.0 nmol
EUR 176
hsa-miR-1179 miRNA Inhibitor
MIH01057 2 x 5.0 nmol
EUR 176
hsa-miR-1180 miRNA Inhibitor
MIH01058 2 x 5.0 nmol
EUR 176

Leave a Comment

Your email address will not be published. Required fields are marked *